TYRA · Tyra Biosciences, Inc. · Executive Compensation
$19.68
-0.72 (-3.51%)
At close · Oct 8
Return incl. dividend (before tax)
Market Cap
$1.22B
Shares
59.68M
Volume · Oct 8
148.5K
Avg daily vol (3M)
853.48K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Todd Harris | Chief Executive Officer | $5,566,997 |
| Bhavesh Ashar | Chief Operating Officer | $4,685,274 |
| Douglas Warner | Chief Medical Officer | $2,372,243 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Todd Harris | Chief Executive Officer | $7,570,066 |
| Douglas Warner | Chief Medical Officer | $4,725,517 |
| Daniel Bensen | Chief Operating Officer | $2,655,199 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Todd Harris | Chief Executive Officer | $4,626,119 |
| Alan Fuhrman | Chief Financial Officer | $3,530,805 |
| Hiroomi Tada | M.D., Ph.D. Chief Medical Officer | $2,412,417 |
| Daniel Bensen | Chief Operating Officer | $1,919,933 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| General Counsel | — | $2,624,708 |
| Daniel Bensen | Chief Operating Officer | $2,429,639 |
| Todd Harris | Chief Executive Officer | $2,287,534 |
| Hiroomi Tada | M.D., Ph.D. Chief Medical Officer | $1,266,737 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Todd Harris | Chief Executive Officer | $6,377,563 |
| Ronald V. Swanson | Chief Scientific Officer | $2,527,901 |
| Hiroomi Tada | M.D., Ph.D. Chief Medical Officer | $2,511,361 |
| Daniel Bensen | Chief Operating Officer | $2,450,780 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Todd Harris | Chief Executive Officer | $1,238,836 |
| Ronald V. Swanson | Chief Scientific Officer | $487,024 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Habib J. Dable | Class II director | Appointed | 2026-04-17 |
| Julia Rueb | principal accounting officer | Appointed | 2026-04-02 |
| Daniel Bensen | Chief Discovery Officer | Appointed | 2025-12-01 |
| Bhavesh Ashar | Chief Operating Officer | Appointed | 2025-12-01 |
| Adele M. Gulfo | director of the Board | Appointed | 2025-01-29 |
| Nina Kjellson | Board and the Compensation Committee of the Board | Resigned | 2025-01-29 |
| Siddarth Subramony, Ph.D. | Board of Directors | Resigned | 2024-10-25 |
| S. Michael Rothenberg, M.D., Ph.D. | directors | Appointed | 2024-05-07 |
| Susan Moran, M.D., M.S.C.E. | directors | Appointed | 2024-05-07 |
| Isan Chen, M.D. | Board and the Compensation Committee of the Board | Resigned | 2024-05-07 |
| Alan Fuhrman | Chief Financial Officer | Appointed | 2022-11-03 |
| Esther van den Boom | Chief Financial Officer | Resigned | 2022-11-03 |